Mandate

Vinge has advised Nordea Bank AB (publ) in connection with a bond issue of up to 1500 MSEK

April 18, 2017 Banking and Finance

Vinge has advised Nordea Bank AB (publ) in connection with a bond issue of up to 1500 MSEK, issued by SBB i Norden AB (publ) on 6 April 2017.

Nordea Bank AB (publ) acted as issuing agent. The bonds have a tenor of three years and a floating interest rate of three-months Stibor plus 6 per cent.

The proceeds from the bond issue will be issued for general corporate purposes, which include financing of property acquisitions. SBB i Norden AB (publ) will apply for the bonds to be listed on Nasdaq Stockholm.

Vinges team consisted of Mikael Ståhl, Josefine Larsson, André Isacson and Lionardo Ojeda.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024